Leiva-Pons JL, Carrillo-Calvillo J, Leiva-Garza JL, Loyo-Olivo MA, Piña-Ramírez BM, López-Quijano JM, Celaya-Lara S, Cerda-Alanís R, Guerrero H

Language: Spanish
References: 12
Page: 178-186
PDF size: 131.86 Kb.

ABSTRACT

The combined use of aspirin and clopidogrel is the standard of care for patients with acute coronary syndromes. The risk for perioperative bleeding is considerably increased after coronary artery by-pass graft surgery (CABG). This study was designed to evaluate the effect of antiplatelet therapy on perioperative CABG outcome. We studied 49 consecutive patients undergoing first time CABG, and compared two groups: Group A, patients who stopped antiplatelet treatment at least 6 days before surgery, and group B, those who received antiplatelet therapy within 5 days before surgery or did not suspended therapy. The groups were comparable in their demographic characteristics, manifestations of disease, perioperative medication use and the characteristics of surgery. There was a non significant tendency for more cardiovascular complications (primary cardiovascular endpoint) in the group that stopped antiplatelet therapy 6 or more days before surgery (Group A 12%, group B 8%; p = 0.923). The bleeding endpoint was significantly higher in group B, that remained on antiplatelet therapy within 5 days before surgery (Group A 4%, group B 29%; p = 0.023), as well as the need for transfusion. We concluded that the combined use of aspirin and clopidogrel before CABG increases postoperative bleeding and morbidity; there was no definitive difference in the cardiovascular outcome.

REFERENCES

1. Antiplatelet Trialists´ Collaboration. Collaborative overview of randomized trials on antiplatelet therapy: Prevention of death, myocardial infraction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:1488-1506. (Erratum, BMJ 1994;308:1504).

2. Yusuf S, Zhao F, Metha SR, Chrolavicius S, Tognoni G, Fox KK, et al: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST- segment elevation. N Engl J Med 2001;345:494-502.

3. Sabatine MS, Cannon CP, Gibson CM, López-Sendon JM, Montalescot G, Theroux P, et al: Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89.

4. Despotis GJ, Hoghe Jr CW: Pathophysiology, prevention, and treatment of bleeding after cardiac surgery: a primer for cardiologist and an update for the cardiothoracic team. Am J Cardiol 1999;83:15B-30B.

5. Peters RJ, Mehta SR, Fox KA, Zhao F, Lewis BS, Kopecky SL, et al: Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Circulation 2003;108:1682-7.

6. Fox KA, Mehta SR, Peters RJ, Zhao F, Lakkis N, Gersh BJ, et al: Benefits of the Combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST elevation acute coronary syndrome. Circulation 2004;110:1202-1208.

7. Hongo RH, Ley J, Dick SE, Yee RR: The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002;40:231-237.

8. COMMIT Collaborative Group: Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infraction: randomized placebo-controlled trial. Lancet 2005;366:1607-21.

9. Van der Linder J, Lindvall G, Sartipy U: Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery, a double –blind, placebo-controlled, randomized clinical trial. Circulation 2005;112 (Suppl 1) I-280.

10. Bybee KA, Powell BD, Valeti U, Rosales AG, Kopecky SL, Mullany C, et al: Preoperative aspirin therapy is associated with improved postoperative outcomes in patients undergoing coronary artery bypass grafting. Circulation 2005;112(Suppl I): I-286-I-292.

11. Dacey LJ, Munoz JJ, Jonhson ER, Leavitt BJ, Maloney CT, Morton JR, et al: Effects of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg 2000;70:1986-90.

12. Mangano DT: Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347: 1309-1317.